NM_001201539.2:c.675T>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001201539.2(ARSF):​c.675T>G​(p.Phe225Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000364 in 1,098,259 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000036 ( 0 hom. 1 hem. )

Consequence

ARSF
NM_001201539.2 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0950

Publications

0 publications found
Variant links:
Genes affected
ARSF (HGNC:721): (arylsulfatase F) This gene is a member of the sulfatase family, and more specifically, the arylsulfatase subfamily. Members of the subfamily share similarity in sequence and splice sites, and are clustered together on chromosome X, suggesting that they are derived from recent gene duplication events. Sulfatases are essential for the correct composition of bone and cartilage matrix. The activity of this protein, unlike that of arylsulfatase E, is not inhibited by warfarin. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jan 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.07765159).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARSFNM_001201539.2 linkc.675T>G p.Phe225Leu missense_variant Exon 6 of 11 ENST00000381127.6 NP_001188468.1 P54793

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARSFENST00000381127.6 linkc.675T>G p.Phe225Leu missense_variant Exon 6 of 11 1 NM_001201539.2 ENSP00000370519.1 P54793
ARSFENST00000359361.2 linkc.675T>G p.Phe225Leu missense_variant Exon 6 of 11 1 ENSP00000352319.2 P54793

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD2 exomes
AF:
0.0000164
AC:
3
AN:
183419
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000216
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000364
AC:
4
AN:
1098259
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
1
AN XY:
363619
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.000132
AC:
4
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54149
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40530
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
842143
Other (OTH)
AF:
0.00
AC:
0
AN:
46098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
22
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 04, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.675T>G (p.F225L) alteration is located in exon 6 (coding exon 5) of the ARSF gene. This alteration results from a T to G substitution at nucleotide position 675, causing the phenylalanine (F) at amino acid position 225 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.43
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
0.082
DANN
Benign
0.27
DEOGEN2
Benign
0.38
T;T
FATHMM_MKL
Benign
0.0088
N
LIST_S2
Benign
0.30
.;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.078
T;T
MetaSVM
Benign
-0.62
T
MutationAssessor
Benign
-1.4
N;N
PhyloP100
-0.095
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.20
N;N
REVEL
Benign
0.28
Sift
Benign
1.0
T;T
Sift4G
Benign
0.85
T;T
Polyphen
0.0010
B;B
Vest4
0.037
MutPred
0.57
Loss of sheet (P = 0.1907);Loss of sheet (P = 0.1907);
MVP
0.99
MPC
0.11
ClinPred
0.010
T
GERP RS
-2.8
Varity_R
0.045
gMVP
0.53
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs763213774; hg19: chrX-3002552; API